The World Health Organization has developed what it claims is the first comprehensive guidance document on data integrity that should help regulatory authorities and inspectors identify instances of pharmaceutical companies submitting insufficient or false data1.
There has recently been "a high level of focus on the small but increasing number" of warning letters issued by...




